Cyxtera Results Presentation Deck
Q3 YTD 2022 Results
Core revenue increased by $30.8 million, or 6.5%, year over year to
$507.5 million
Transaction Adjusted EBITDA increased by $0.7 million or 0.3% year
over year, principally due to higher revenue partially offset by higher
higher cost of revenue and SG&A costs
Cyxtera
($ in Millions)
Recurring Revenue
Non-Recurring Revenue
Total Revenue
Cost of Revenue
As a % of Revenue
Gross Profit
% Margin
Total SG&A
As a % of Revenue
Other (1)
EBITDA
% Margin
Transaction Adjustments
Transaction Adjusted EBITDA (2)
% Margin
Rent (net of adjustments)
Transaction Adjusted EBITDAR(3)
% Margin
Capital Expenditures
As a % of Revenue
Q3 YTD
2022
$526.0
27.0
$553.0
$296.7
53.7%
$256.3
46.3%
$103.8
18.8%
($7.9)
$160.4
29.0%
$16.7
$177.1
32.0%
$45.6
$222.6
40.3%
$102.8
18.6%
Q3 YTD
2021
$501.2
24.1
$525.3
$287.4
54.7%
$238.0
45.3%
$79.7
15.2%
(1) Q3 22 YTD includes ($11.8M) benefit related to change in fair value of derivative liabilities, offset by $3.9M in restructuring, impairment, site closures and related cost. Q3 21 YTD includes $71.1M in restructuring, impairment, site closures and related cost
(2) Earnings Before Interest, Taxes, Depreciation, Amortization
(3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent
$76.3
$82.0
15.6%
$94.5
$176.4
33.6%
$46.0
$222.5
42.4%
$48.5
9.2%
YOY Change
4.9%
12.3%
5.3%
3.3%
(105 bps)
7.7%
105 bps
30.2%
360 bps
ΝΑ
95.7%
1,340 bps
0.3%
(157 bps)
0.1%
(210 bps)
112.0%
936bps
12View entire presentation